Research paper
Calcium plus vitamin D supplementation and the risk of fractures.
- R. Jackson
- A. LaCroix
- M. Gass
- R. Wallace
- J. Robbins
- Cora E. Lewis
- T. Bassford
- S. Beresford
- H. Black
- P. Blanchette
- D. Bonds
- R. Brunner
- R. Brzyski
- B. Caan
- J. Cauley
- R. Chlebowski
- S. Cummings
- Iris A. Granek
- J. Hays
- G. Heiss
- S. Hendrix
- B. Howard
- J. Hsia
- F. Hubbell
- K. Johnson
- H. Judd
- J. Kotchen
- L. Kuller
- R. Langer
- N. Lasser
- M. Limacher
- S. Ludlam
- J. Manson
- K. Margolis
- J. McGowan
- J. Ockene
- M. O'sullivan
- L. Phillips
- R. Prentice
- G. Sarto
- M. Stefanick
- L. V. Van Horn
- J. Wactawski‐Wende
- E. Whitlock
- G. Anderson
- A. Assaf
- D. Barad
Study answer
What this study found
Calcium plus vitamin D did not significantly reduce hip fracture or total fractures, although it produced a small improvement in hip bone density. Hip fracture occurred in 175 women in the calcium plus vitamin D group versus 199 in placebo (hazard ratio 0.88, 95% CI 0.72-1.08), and total fractures occurred in 2102 versus 2158 (hazard ratio 0.96, 95% CI 0.91-1.02). Hip bone density was 1.06 percent higher in the calcium plus vitamin D group (P<0.01), and the adherence-adjusted hip fracture hazard ratio was 0.71 (0.52-0.97). The regimen increased renal calculi risk (hazard ratio 1.17, 95% CI…
- Study & population
- Randomized, placebo-controlled trial in healthy postmenopausal women aged 50 to 79 years enrolled at 40 Women's Health Initiative clinical centers in the United States.
- Intervention
- The active regimen was oral calcium carbonate plus vitamin D3: each tablet contained 500 mg elemental calcium and 200 IU vitamin D3, taken as two tablets per day in divided doses with meals.
- Key limitation
- Fracture outcomes were not significantly improved in the intention-to-treat analysis despite a bone density benefit, and adherence influenced the apparent hip-fracture reduction.
Original abstract
BACKGROUND The efficacy of calcium with vitamin D supplementation for preventing hip and other fractures in healthy postmenopausal women remains equivocal. METHODS We recruited 36,282 postmenopausal women, 50 to 79 years of age, who were already enro…